MAGEA9 Antikörper (Middle Region)
Kurzübersicht für MAGEA9 Antikörper (Middle Region) (ABIN927539)
Target
Alle MAGEA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- MAGEA9 antibody was raised in rabbit using the middle region of MAGEA9 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
MAGEA9 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this MAGEA9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAGEA9 (Melanoma Antigen Family A, 9 (MAGEA9))
-
Andere Bezeichnung
- MAGEA9
-
Hintergrund
- MAGEA9 is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Synonyms: Polyclonal MAGEA9 antibody, Anti-MAGEA9 antibody, melanoma antigen family A, 9 antibody, MAGE9 antibody, MGC8421 antibody.
Target
-